Abstract
High-grade B-cell lymphoma with 11q aberration (HGBCL-11q) is a rare pediatric non-Hodgkin lymphoma. This study assessed outcome in 90 children with HGBCL-11q. With survival rates ≥95%, patients with HGBCL-11q and no predisposition are candidates for deescalated therapy in future prospective trials.
References
1.
Alaggio
R
, Amador
C
, Anagnostopoulos
I
, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms
. Leukemia
. 2022
;36
(7
):1720
-1748
.2.
Campo
E
, Dierickx
D
, Dirnhofer
S
, et al. Lymphoma classifications, how to develop a future unified taxonomy
. J Clin Oncol
. 2024
;42
(27
):3177
-3182
.3.
Zanelli
M
, Sanguedolce
F
, Zizzo
M
, et al. A diagnostic approach in large B-cell lymphomas according to the fifth World Health Organization and International Consensus Classifications and a practical algorithm in routine practice
. Int J Mol Sci
. 2024
;25
(23
):13213
.4.
Xavier
AC
, Attarbaschi
A
, Gratzinger
D
, Balagué
O
. Dedicated diagnostic approaches for mature B-cell non-Hodgkin lymphomas occurring in children, adolescents, and young adults
. Histopathology
. 2025
;86
(1
):17
-37
.5.
Quintanilla-Martinez
L
, Laurent
C
, Soma
L
, et al. Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH Lymphoma Workshop
. Virchows Arch
. 2023
;483
(3
):281
-298
.6.
Salaverria
I
, Martin-Guerrero
I
, Wagener
R
, et al. A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma
. Blood
. 2014
;123
(8
):1187
-1198
.7.
Wagener
R
, Seufert
J
, Raimondi
F
, et al. The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma
. Blood
. 2019
;133
(9
):962
-966
.8.
Di Stefano
G
, Fischer
A
, Chteinberg
E
, et al. MicroRNA expression in high-grade B-cell lymphoma with 11q aberration
. Genes Chromosomes Cancer
. 2025
;64
(1
):e70021
.9.
Au-Yeung
RKH
, Arias Padilla
L
, Zimmermann
M
, et al. Experience with provisional WHO-entities large B-cell lymphoma with IRF4 -rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group
. Br J Haematol
. 2020
;190
(5
):753
-763
.10.
Gonzalez-Farre
B
, Ramis-Zaldivar
JE
, Salmeron-Villalobos
J
, et al. Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma
. Haematologica
. 2019
;104
(9
):1822
-1829
.11.
Elitzur
S
, Shiloh
R
, Loeffen
JLC
, et al. ATM germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies
. Blood
. 2024
;144
(11
):1193
-1205
.12.
Ferreiro
JF
, Morscio
J
, Dierickx
D
, et al. Post-transplant molecularly defined Burkitt lymphomas are frequently MYC-negative and characterized by the 11q-gain/loss pattern
. Haematologica
. 2015
;100
(7
):e275
-e279
.13.
14.
Jourdain
A
, Auperin
A
, Minard-Colin
V
, et al. Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective “Lymphomes Malins B” protocols. A Société Française des Cancers de l'Enfant study
. Haematologica
. 2015
;100
(6
):810
-817
.15.
Minard-Colin
V
, Aupérin
A
, Pillon
M
, et al. Rituximab for high-risk, mature B-cell non-Hodgkin’s lymphoma in children
. N Engl J Med
. 2020
;382
(23
):2207
-2219
.16.
Rigaud
C
, Auperin
A
, Jourdain
A
, et al. Outcome of relapse in children and adolescents with B-cell non-Hodgkin lymphoma and mature acute leukemia: a report from the French LMB study
. Pediatr Blood Cancer
. 2019
;66
(9
):e27873
.17.
Rosolen
A
, Perkins
SL
, Pinkerton
CR
, et al. Revised international pediatric non-Hodgkin lymphoma staging system
. J Clin Oncol
. 2015
;33
(18
):2112
-2118
.18.
Tsurusawa
M
, Mori
T
, Kikuchi
A
, et al. Improved treatment results of children with B-cell non-Hodgkin lymphoma: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group B-NHL03 study
. Pediatr Blood Cancer
. 2014
;61
(7
):1215
-1221
.19.
Woessmann
W
, Seidemann
K
, Mann
G
, et al. The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95
. Blood
. 2005
;105
(3
):948
-958
.20.
Murphy
SB
. Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults
. Semin Oncol
. 1980
;7
(3
):332
-339
.21.
Kim
JA
, Kim
H-Y
, Kim
SJ
, Kim
HJ
, Kim
SH
. A case of Burkitt-like lymphoma with 11q aberration with HIV infection in East Asia and literature review
. Ann Lab Med
. 2021
;41
(6
):593
-597
.22.
Attarbaschi
A
, Carraro
E
, Abla
O
, et al. Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescents
. Haematologica
. 2016
;101
(12
):1581
-1591
.23.
Attarbaschi
A
, Carraro
E
, Ronceray
L
, et al. Second malignant neoplasms after treatment of non-Hodgkin's lymphoma-a retrospective multinational study of 189 children and adolescents
. Leukemia
. 2021
;35
(2
):534
-549
.24.
Attarbaschi
A
, Abla
O
, Arias Padilla
L
, et al. Rare non-Hodgkin lymphoma of childhood and adolescence: a consensus diagnostic and therapeutic approach to pediatric-type follicular lymphoma, marginal zone lymphoma, and nonanaplastic peripheral T-cell lymphoma
. Pediatr Blood Cancer
. 2020
;67
(8
):e28416
.25.
Xavier
AC
, Suzuki
R
, Attarbaschi
A
. Diagnosis and management of rare paediatric non-Hodgkin lymphoma
. Best Pract Res Clin Haematol
. 2023
;36
(1
):101440
.© 2026 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
2026
You do not currently have access to this content.
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal